Gait in mild Alzheimer’s disease: feasibility of multi-centre measurement in the clinic and home with body-worn sensors: a pilot study
Gait is emerging as a potential diagnostic tool for cognitive decline. The ‘Deep and Frequent Phenotyping for Experimental Medicine in Dementia Study’ (D&FP;) is a multicenter feasibility study embedded in the United Kingdom Dementia Platform designed to determine participant acceptability a...
Main Authors: | Mc Ardle, R, Morris, R, Hickey, A, Del Din, S, Koychev, I, Gunn, RN, Lawson, J, Zamboni, G, Ridha, B, Sahakian, BJ, Rowe, JB, Thomas, A, Zetterberg, H, MacKay, C, Lovestone, S, Rochester, L, Deep and Frequent Phenotyping study team |
---|---|
Format: | Journal article |
Language: | English |
Published: |
IOS Press
2018
|
Similar Items
-
PET tau and amyloid-β burden in mild Alzheimer's disease: divergent relationship with age, cognition and cerebrospinal fluid biomarkers
by: Koychev, I, et al.
Published: (2017) -
Aβ42/Aβ40 and Aβ42/Aβ38 ratios are associated with measures of gait variability and activities of daily living in mild Alzheimer's disease: a pilot study
by: Koychev, I, et al.
Published: (2018) -
Tau pathology in early Alzheimer's disease is linked to selective disruptions in neurophysiological network dynamics
by: Kocagoncu, E, et al.
Published: (2020) -
Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451
by: Firouzian, A, et al.
Published: (2018) -
User Attention with Head-Worn Displays
by: Farve, Niaja, et al.
Published: (2020)